Thomas Flaten
Stock Analyst at Lake Street
(2.67)
# 2,147
Out of 4,981 analysts
29
Total ratings
35.48%
Success rate
1.47%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.11 | +82.84% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $3.03 | +164.46% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.09 | +97.46% | 2 | Jul 18, 2025 | |
| AYTU Aytu BioPharma | Initiates: Buy | $8 | $2.36 | +238.98% | 1 | Jul 1, 2025 | |
| BDSX Biodesix | Maintains: Buy | $3 → $2 | $0.38 | +433.19% | 1 | May 14, 2025 | |
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $21.42 | +63.40% | 6 | May 6, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $5.05 | +58.42% | 2 | Mar 7, 2025 | |
| EVAX Evaxion | Maintains: Buy | $35 → $6 | $2.95 | +103.74% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $5.85 | +53.85% | 2 | Jan 8, 2025 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.81 | +268.87% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $3.08 | +257.14% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $25.51 | -2.00% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.11 | +68,146.45% | 2 | Nov 17, 2022 |
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.11
Upside: +82.84%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $3.03
Upside: +164.46%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.09
Upside: +97.46%
Aytu BioPharma
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.36
Upside: +238.98%
Biodesix
May 14, 2025
Maintains: Buy
Price Target: $3 → $2
Current: $0.38
Upside: +433.19%
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $21.42
Upside: +63.40%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $5.05
Upside: +58.42%
Evaxion
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $2.95
Upside: +103.74%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $5.85
Upside: +53.85%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.81
Upside: +268.87%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $3.08
Upside: +257.14%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $25.51
Upside: -2.00%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.11
Upside: +68,146.45%